Objectives

• Lead the focus of sex/gender medicine towards metabolic diseases with a high prevalence in Spain.
• Lead the transfer research in reproductive endocrinology and intermediary metabolism.
• Lead the transfer of scientific knowledge to the clinical practice in reproductive endocrinology.

Research lines

• Evolution of obesity-related female androgen excess after weight loss.
• Evolution of obesity-related male hypogonadism after weight loss.
• Influence of obesity and gonadal dysfunction on early cardiovascular disease markers and cardiovascular risk markers.
• Obesity as a cardiovascular risk factor in males and females.
• Adipose tissue and intermediary metabolism dysfunction after the treatment of androgen deficiency in males.
• Adipose tissue and intermediary metabolism dysfunction after the treatment of androgen excess in females.